Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070003 · ClinicalTrials.gov registry record · NA
Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT02070003: Completed NA study, sponsored by Stanford University.
NCT02070003 is a NA study that has completed, run by Stanford University. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02070003, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The investigators aim to characterize the relationship between changes in emotional distress, opioid use, and pain throughout surgery and recovery. Additionally, the investigators aim to compare the effectiveness of post-surgical motivational interviewing and physician-guided opioid weaning vs. usual care on reducing persistent opioid use. Overall, the proposed research will advance knowledge regarding the role of psychological factors contributing to persistent opioid use after surgery.
Primary Outcome
Factors that contribute to non-completion of the study, measured at baseline for each patient, will be analyzed.
Interventions
- BEHAVIORAL Motivational Interviewing and Physician Guided Opioid Weaning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2014-11-26 |
| Est. Completion | 2018-08-15 |
| Phase | NA |
What the finished NCT02070003 record still lists
NCT02070003 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Motivational Interviewing and Physician Guided Opioid Weaning is the first listed.
NCT02070003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02070003 about?
NCT02070003 is a clinical study titled "Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)". The investigators aim to characterize the relationship between changes in emotional distress, opioid use, and pain throughout surgery and recovery. Additionally, the investigators aim to compare the effectiveness of post-surgical motivational interviewing and physician-guided opioid weaning vs. usua...
What is the current status of trial NCT02070003?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2014-11-26. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT02070003?
The interventions under investigation include: Motivational Interviewing and Physician Guided Opioid Weaning (BEHAVIORAL).
Who is sponsoring clinical trial NCT02070003?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02070003's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI